Product ID |
Product Name |
CAS# |
Purity |
Y4004569 |
2-(Phenylcarbamoyl)benzoic Acid |
4727-29-1 |
95% |
Y4003461 |
3-Oxopropionitrile |
6162-76-1 |
95% |
Y4000057 |
1,1-Difluoro-2-propanamine |
431-00-5 |
95% |
Y4007204 |
Ethyl 6-Methylpyridazine-4-carboxylate |
42602-52-8 |
95% |
Y4011433 |
3-Hydroxy-5-(methoxycarbonyl)phenylboronic Acid |
1429324-74-2 |
95% |
Y4007145 |
6-Amino-4-hydroxypyridazine |
1935402-93-9 |
95% |
Y4012512 |
2-Amino-1H-imidazole-4-acetic Acid |
73086-08-5 |
95% |
Y4001662 |
5-Chloro-2-phenylbenzothiazole |
952-16-9 |
95% |
Y4005505 |
2-(4-Aminophenyl)-6-(tert-butyl)-1H-pyrazolo[1,5-b][1,2,4]triazole |
152828-25-6 |
95% |
Y4000401 |
Tripalmitin |
555-44-2 |
95% |
Y4001772 |
(E)-Hept-2-en-1-ol |
33467-76-4 |
96% |
Y4004338 |
2-Methylstyrene |
611-15-4 |
95% |
Y4005157 |
1,2,3,4-Tetrafluoro-5-(trifluoromethyl)benzene |
654-53-5 |
95% |
Y4007499 |
1-Tridecanol |
112-70-9 |
97% |
Y4006407 |
1,2-Dimethylnaphthalene |
573-98-8 |
95% |
Y4001075 |
3a,4,7,7a-Tetrahydro-1H-indene |
3048-65-5 |
98% |
Y4008195 |
4-Ethylcyclohexanamine |
42195-97-1 |
95% |
Y4010249 |
3-Ethyl-2-pentene |
816-79-5 |
95% |
Y4012211 |
4-Methacryloyloxy-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical |
15051-46-4 |
97% |
Y4011343 |
Nonanoic Anhydride |
1680-36-0 |
97% |
Y4001554 |
1-Tricosanol |
3133-01-5 |
95% |
Y4002846 |
6-Heptenyl Acetate |
5048-30-6 |
97% |
Y4006456 |
3-Fluoro-4-hydroxybenzimidamide Hydrochloride |
271799-21-4 |
95% |
Y4009549 |
6-Fluoro-1-naphthaldehyde |
1261488-86-1 |
95% |
Y4005678 |
1,2-Epoxycyclododecane |
286-99-7 |
95% |
Y4000514 |
O-(tert-Butyl)-L-serine Methyl Ester |
17083-26-0 |
95% |
Y4006705 |
Potassium Hexacyanoplatinate(IV) |
16920-94-8 |
95% |
Y4001617 |
N,N-Dimethylindoline-5-sulfonamide |
99169-99-0 |
95% |
Y4001781 |
5-Fluoro-2-(trifluoromethyl)benzamide |
654-95-5 |
95% |
Y4013382 |
Sodium 3-Chloro-4-methylbenzenesulfinate |
144772-86-1 |
95% |
Y4005093 |
Bis(ethylenediamine)copper(II) Hydroxide |
14552-35-3 |
95% |
Y4006049 |
Dihexylamine Acetate, 0.5 M solution in H2O |
366793-17-1 |
N/A |
Y4011490 |
(S)-1-(1H-Benzimidazol-2-yl)-3-methylbutylamine |
59592-31-3 |
95% |
Y4002203 |
(2S,2'S)-[N,N'-Bis(2-pyridylmethyl)]-2,2'-bipyrrolidinebis(acetonitrile)iron(II) Hexafluoroantimonate |
959395-10-9 |
95% |
Y4008847 |
3-Amino-5-azaindole Dihydrochloride |
1257535-49-1 |
95% |
Y4010758 |
1-[2-(Trifluoromethyl)-4-pyridyl]ethanamine |
1060811-09-7 |
95% |
Y4009255 |
Ethyl 5-(3-Furyl)-1,2,4-oxadiazole-3-carboxylate |
1086375-75-8 |
95% |
Y4011109 |
5-(5-Pyrazolyl)-2-(trifluoromethyl)pyridine |
1097778-72-7 |
95% |
Y4000042 |
6-(Aminomethyl)pyridin-2(1H)-one |
131052-62-5 |
95% |
Y4006776 |
Chloro[(1,2,3-η)-1-phenyl-2-propen-1-yl]-[[1,3-bis[2,6-bis(diphenylmethyl)-4-methylphenyl]-2H-imidazol-2-ylidene]palladium(II) |
1380314-24-8 |
95% |
Y4012468 |
(S)-1-(Azetidin-3-yl)pyrrolidin-3-ol Hydrochloride |
1449131-14-9 |
95% |
Y4003908 |
(R)-1-(Azetidin-3-yl)pyrrolidin-3-ol Hydrochloride |
1449131-16-1 |
95% |
Y4004153 |
Bis(3-hydroxy-2,2,6,6-tetramethyl-5-oxohept-3-en-1-yl)cerium |
18960-54-8 |
98% |
Y4013375 |
2-(6-Hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic Acid |
20240-21-5 |
95% |
Y4005952 |
(S)-5,5'-Bis[di(3,5-xylyl)phosphino]-4,4'-bi-1,3-benzodioxole |
210169-57-6 |
min. 98% |
Y4007320 |
Tetrabenzylzirconium |
24356-01-2 |
95% |
Y4006816 |
N,N'-Diisopropylformimidamide |
44843-38-1 |
95% |
Y4000354 |
(S)-6,6'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-5,5'-bibenzo[b][1,4]dioxine |
503538-68-9 |
95% |
Y4010258 |
[Difluoro(phenylsulfonyl)methyl]trimethylsilane |
536975-50-5 |
95% |
Y4004390 |
3-(4-Bromo-1-pyrazolyl)benzonitrile |
546142-07-8 |
95% |
Y4010585 |
1-Carbamoylpiperidine-4-carboxylic Acid |
851168-77-9 |
98% |
Y4006651 |
6,7-Dimethylbenzo[d]thiazol-2-amine |
854057-72-0 |
95% |
Y4005523 |
3-Bromo-5-(4-fluorophenyl)isoxazole |
903130-97-2 |
95% |
Y4009603 |
Platinum meso-Tetra(4-carboxyphenyl)porphine |
94288-45-6 |
95% |
Y4011655 |
2-Bromo-N-(4-sulfamoylphenyl)acetamide |
5332-70-7 |
95% |
Y4006829 |
3-(Dimethylamino)-1-(4-pyridyl)-2-propen-1-one |
66521-53-7 |
95% |
Y4008751 |
1-Isopropyl-3-methyl-1H-pyrazol-4-amine Hydrochloride |
1257554-91-8 |
95% |
Y4003562 |
Ethyl 2-Amino-2-methylpropanoate |
1113-49-1 |
95% |
Y4012486 |
1-[4-(2,2-Difluoroethoxy)-3-methoxyphenyl]ethanamine Hydrochloride |
1373866-16-0 |
95% |
Y4013215 |
3-Amino-5-(methoxymethyl)-1-methyl-1H-pyrazole |
1328640-82-9 |
95% |
Y4011538 |
4-[(2-Chloro-4-formylphenoxy)methyl]benzoic Acid |
433250-58-9 |
95% |
Y4005514 |
5-Chloro-2,3-dimethoxybenzoic Acid |
72517-22-7 |
95% |
Y4007085 |
(R)-7'-[(R)-Hydroxy(phenyl)methyl]-2,2',3,3'-tetrahydro-1,1'-spirobi[inden]-7-ol |
1451057-23-0 |
95% |
Y4002357 |
(S)-2-Hydroxy-2'-[(R)-hydroxy(phenyl)methyl]-[1,1'-binaphthalene] |
1281985-73-6 |
95% |
Y4001212 |
(S)-2-Hydroxy-2'-[(S)-hydroxy(phenyl)methyl]-[1,1'-binaphthalene] |
1360825-43-9 |
95% |
Y4008668 |
(R)-2-Hydroxy-2'-[(S)-hydroxy(4-pyridyl)methyl]-[1,1'-binaphthalene] |
1498319-67-7 |
95% |
Y4011602 |
2-Hydroxy-3-(diphenylphosphino)-2'-[hydroxy[2-(triethylsilyl)phenyl]methyl]-[1,1'-binaphthalene] |
1661883-81-3 |
95% |
Y4009291 |
2'-[2-Biphenylyl(hydroxy)methyl]-2-hydroxy-3-(diphenylphosphino)-[1,1'-binaphthalene] |
1661883-77-7 |
95% |
Y4007162 |
(R)-3-(Diphenylphosphino)-[1,1'-binaphthalene]-2,2'-diol |
1227504-74-6 |
95% |
Y4008672 |
2'-Benzyl-2-hydroxy-3-(diphenylphosphino)-[1,1'-binaphthalene] |
1621627-50-6 |
95% |
Y4007902 |
(1R,1''R)-3,3''-[[(1S,2S)-Cyclohexane-1,2-diylbis(azanediyl)]bis(methylene)]bis(2'-benzyl-[1,1'-binaphthalen]-2-ol) |
1403589-08-1 |
95% |
Y4011127 |
3,3''-[[(1,2-Diphenylethane-1,2-diyl)bis(azanylylidene)]bis(methanylylidene)]bis(2'-benzyl-2-hydroxy-[1,1'-binaphthalene]) |
1800468-70-5 |
95% |
Y4003298 |
1α-Hydroxy-3-deoxypseudoanisatin |
258854-65-8 |
≥98% |
Y4003299 |
Gymnoside I |
899430-01-4 |
≥98% |
Y4003300 |
Qianhucoumarin D |
20516-19-2 |
≥98% |
Y4003307 |
4-Bromo-2-chloro-3-methylbenzaldehyde |
2010198-18-0 |
96% |
Y4003305 |
Lapatinib-d4 |
1184263-99-7 |
99% |
Y4000637 |
Human PD-L1 inhibitor I |
2135542-86-6 |
98.93% |
Y4003308 |
1-(3-Bromophenyl)pentan-1-one |
174496-36-7 |
96% |
Y4003310 |
4-(((3R,5S)-1-(1-(((2R,3R,4R,5R,6R)-3-Acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-16,16-bis((3-((3-(5-(((2R,3R,4R,5R,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydr |
1159408-61-3 |
98% |
Y4003312 |
4-Bromo-6-fluoro-1-methyl-1H-indazole |
1369876-51-6 |
97% |
Y4003615 |
tert-butyl N-(4-bromo-2,5-difluorophenyl)carbamate |
1874418-51-5 |
97% |
Y4003614 |
Cytochalasin R |
121964-47-4 |
≥95% |
Y4003620 |
1-bromo-2-chloro-3-(methylsulfanyl)-4-(trifluoromethoxy)benzene |
2167830-09-1 |
97% |
Y4003618 |
1,3,5-Trifluoro-2-[2-(trimethylsilyl)ethynyl]benzene |
2554782-16-8 |
96% |
Y4003621 |
5-bromo-6-isopropylpyridin-2-amine |
1505779-13-4 |
97% |
Y4003628 |
4-methyl-1-nitro-2-phenoxybenzene |
60287-60-7 |
97% |
Y4003625 |
4-(tert-Butoxy)-2-((tert-butoxycarbonyl)amino)-4-oxobutanoic acid |
1016259-17-8 |
98% |
Y4003626 |
4-Bromo-3-(methoxymethyl)benzoic acid |
1141473-98-4 |
95% |
Y4003627 |
1-(4-Chloro-2-fluorophenyl)-2,2,2-trifluoroethan-1-ol |
1514167-13-5 |
97% |
Y4003630 |
2-(Trifluoromethoxy)isoindoline-1,3-dione |
1624625-77-9 |
98% |
Y4003635 |
(2R,5R)-1,2,5-Trimethylpiperazine dihydrochloride |
2940869-65-6 |
95% |
Y4000639 |
1-Iodo-2-(methylsulfonyl)benzene |
110483-14-2 |
97% |
Y4001992 |
Methyl 3-Bromo-4-hydroxy-5-methylbenzoate |
2090296-22-1 |
97% |
Y4003636 |
SAH-SOS1A TFA |
2896737-31-6 |
99.16% |
Y4003637 |
c-Myc Peptide TFA |
2918768-02-0 |
99.84% |
Y4003646 |
1-(P-tolyl)prop-2-en-1-ol |
58824-48-9 |
97% |
Y4003654 |
2-(4-(Dimethylamino)phenyl)-2-oxoacetic acid |
63756-72-9 |
95% |
Y4003647 |
3-Fluoro-5-methoxy-4-methylbenzoic acid |
1427433-86-0 |
97% |
Y4003648 |
2-Bromo-3,5-dimethylaniline |
35490-76-7 |
97% |